Clinical trial
A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in…
NCT00040677 · Icagen, Industry · Completed
Key facts
| NCT number | NCT00040677 |
|---|---|
| Title | A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia. |
| Official title | A Phase II, Multicenter, Twelve-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Range-Finding Study of the Efficacy and Safety of ICA-17043 With or Without Hydroxyurea Therapy in Patients With Sickle Cell Anemia |
| Lead sponsor | Icagen, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Sickle Cell Disease, Sickle Cell Anemia |
| Intervention type | Drug |
| Interventions | Low Dose ICA-17043, High dose ICA-17043, Placebo |
| Enrollment | 90 |
| Start date | Feb 1, 2002 |
| Primary completion | Nov 1, 2003 |
| Completion | Jan 1, 2004 |
| First posted | Jul 10, 2002 |
| Last update posted | Jul 18, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: